SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zylo Therapeutics
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: donpat1/31/2018 2:05:25 PM
  Read Replies (1) of 19
 
Novan - another nitric oxide centered company:

investors.novan.com

Stock Information more >>
NOVN (Common Stock)$3.31 - 0.18 (5.16%)
ExchangeNASDAQ
Volume68,690
Today's Open$3.58
Previous Close$3.49
Data as of 01/31/18 1:28 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

10/21/16
Form 8937 Conversion of Preferred Stock to Common Stock
10/21/16
Form 8937 Reverse Stock Split


Events more >>
There are currently no events scheduled.

Presentation more >>

DateTitle
10/24/17
Novan Corporate Presentation


Get help downloading or viewing the above file types

Analyst Coverage more >>
FirmAnalyst
JMP SecuritiesDonald Ellis, Pharm.D.
Piper Jaffray & Co.David Amsellem
Wedbush SecuritiesDavid M. Nierengarten, Ph.D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News